Erika Sutanto‐Ward

2.0k citations
22 papers · 1.6k indexed · 1 hit paper · h-index 14
Topics
Tryptophan and brain disorders (8 papers)Hepatocellular Carcinoma Treatment and Prognosis (6 papers)Immune cells in cancer (5 papers)

In The Last Decade

Erika Sutanto‐Ward

21 papers receiving 1.6k citations

Hit Papers

Inhibition of indoleamine 2,3-dioxygenase, an immunoregul...20052026201220192005250500750

Peers

Erika Sutanto‐Ward
Comparison fields: 5 of 86
  • Biological Psychiatry 876
  • Immunology 597
  • Molecular Biology 544
  • Oncology 414
  • Psychiatry and Mental health 282
Replace Lisa D. Laury‐Kleintop with:
Lisa D. Laury‐Kleintop United States
Preston S. Donover United States
Kevin Bowman United States
Jen‐Shin Song Taiwan
Rogier C. Buijsman Netherlands
Pradeep Bista United States
Sowmya Chollate United States
Sazzad Hassan United States
Rebecca Conrad Germany
Chantal Bazenet United Kingdom
Erika Sutanto‐Ward relative to Lisa D. Laury‐Kleintop United States Lisa D. Laury‐Kleintop's profile →
Citations per field
00.5×1.5×
Lisa D. Laury‐Kleintop · 1×
Citations per year

Countries citing papers authored by Erika Sutanto‐Ward

Since Specialization
Citations

This map shows the geographic impact of Erika Sutanto‐Ward's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erika Sutanto‐Ward with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erika Sutanto‐Ward more than expected).

Fields of papers citing papers by Erika Sutanto‐Ward

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erika Sutanto‐Ward. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erika Sutanto‐Ward. The network helps show where Erika Sutanto‐Ward may publish in the future.

Co-authorship network of co-authors of Erika Sutanto‐Ward

This figure shows the co-authorship network connecting the top 25 collaborators of Erika Sutanto‐Ward. A scholar is included among the top collaborators of Erika Sutanto‐Ward based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erika Sutanto‐Ward. Erika Sutanto‐Ward is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 24
4 36
5 41
6 75
7 260
8 43
9 23
10 36
11 150
12
Transcriptional control of IDO by the cancer suppression gene Bin1, a key mechanism for restraining tumor immune escape
1
13
Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapybreakdown →
873
14 17
15 1
16 4
17 15
18 4
19 17
20 14

About Erika Sutanto‐Ward

Erika Sutanto‐Ward is a scholar working on Biological Psychiatry, Hepatology and Behavioral Neuroscience, having authored 22 papers that have together received 1.6k indexed citations. Recurring topics across this work include Tryptophan and brain disorders (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Immune cells in cancer (5 papers). The work is most often cited by research in Biological Psychiatry (876 citations), Behavioral Neuroscience (268 citations) and Immunology (597 citations). Erika Sutanto‐Ward has collaborated with scholars based in United States, Denmark and Ireland. Frequent co-authors include James B. DuHadaway, Alexander J. Muller, George C. Prendergast, Preston S. Donover, Laura Mandik‐Nayak, Alejandro Peralta Soler, Janette Boulden, Courtney Smith, Mee Young Chang and Lisa D. Laury‐Kleintop. Their work appears in journals such as Nature Medicine, Cancer Research and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026